Intracellular antimicrobial activity appearing as a relevant factor in antibiotic efficacy against an experimental foreign-body infection caused by Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 5, 2009, Pages

  Murillo, O ^a   Pachon M E ^a   Euba, G ^a   Verdaguer, R ^a   Carreras, M ^a   Cabellos, C ^a   Cabo, J ^a   Gudiol, F ^a   Ariza, J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Animal model; Device related infections; Intracellular bacteria; Intracellular infection; Staphylococci

Indexed keywords

CLOXACILLIN; LEVOFLOXACIN; ANTIINFECTIVE AGENT; OFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL SURVIVAL; CONTROLLED STUDY; DEVICE INFECTION; DRUG EFFICACY; INTRACELLULAR BACTERIUM; INTRACELLULAR KILLING; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; RAT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; ANIMAL; CYTOPLASM; DISEASE MODEL; DRUG EFFECT; FOREIGN BODY; ISOLATION AND PURIFICATION; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; CLOXACILLIN; COLONY COUNT, MICROBIAL; CYTOPLASM; DISEASE MODELS, ANIMAL; FOREIGN BODIES; OFLOXACIN; RATS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 73949153087     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp326     Document Type: Article

References (26)

1. Zimmerli W, Trampuz A, Ochsner PE. Prosthetic-joint infections. N Engl J Med 2004; 351: 1645-54.
2. Chuard C, Lucet JC, Rohner P et al. Resistance of Staphylococcus aureus recovered from infected foreign body in vivo to killing by antimicrobials. J Infect Dis 1991; 163: 1369-73.
3. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284: 1318-22.
4. Zimmerli W, Lew PD, Waldvogel FA. Pathogenesis of foreign body infection. Evidence for a local granulocyte defect. J Clin Invest 1984; 73: 1191-200.
5. Vaudaux P, Suzuki R, Waldvogel FA et al. Foreign body infection: role of fibronectin as a ligand for the adherence of Staphylococcus aureus. J Infect Dis 1984; 150: 546-53.
6. Maurin M, Raoult D. Intracellular organisms. Int J Antimicrob Agents 1997; 9: 61-70.
7. Gresham HD, Lowrance JH, Caver TE et al. Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol 2000; 164: 3713-22.
8. Ellington JK, Harris M, Hudson MC et al. Intracellular Staphylococcus aureus and antibiotic resistance: implications for treatment of staphylococcal osteomyelitis. J Orthop Res 2006; 24: 87-93.
9. Rogers DE, Tompsett R. The survival of staphylococci within human leukocytes. J Exp Med 1952; 95: 209-30.
10. Sendi P, Rohrbach M, Graber P et al. Staphylococcus aureus small colony variants in prosthetic joint infection. Clin Infect Dis 2006; 43: 961-7.
11. Vaudaux P, Kelley WL, Lew DP. Staphylococcus aureus small colony variants: difficult to diagnose and difficult to treat. Clin Infect Dis 2006; 43: 968-70.
12. Lucet JC, Herrmann M, Rohner P et al. Treatment of experimental foreign body infection caused by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1990; 34: 2312-7.
13. Zimmerli W, Waldvogel FA, Vaudaux P et al. Pathogenesis of foreign body infection: description and characteristics of an animal model. J Infect Dis 1982; 146: 487-97.
14. Murillo O, Domenech A, Garcia A et al. Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillinsusceptible Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50: 4011-7.
15. Murillo O, Pachon ME, Euba G et al. Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection. Antimicrob Agents Chemother 2008; 52: 3681-6.
16. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically-Eighth Edition: Approved Standard M07-A8. CLSI, Wayne, PA, USA, 2009.
17. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998; 26: 1-10.
18. Hampton MB, Vissers MC, Winterbourn CC. A single assay for measuring the rates of phagocytosis and bacterial killing by neutrophils. J Leukoc Biol 1994; 55: 147-52.
19. Hiramatsu K, Aritaka N, Hanaki H et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670-3.
20. Graham L, Orenstein JM. Processing tissue and cells for transmission electron microscopy in diagnostic pathology and research. Nat Protoc 2007; 2: 2439-50.
21. Widmer AF, Frei R, Rajacic Z et al. Correlation between in vivo and in vitro efficacy of antimicrobial agents against foreign body infections. J Infect Dis 1990; 162: 96-102.
22. Espersen F, Frimodt-Moller N, Corneliussen L et al. Effect of treatment with methicillin and gentamicin in a new experimental mouse model of foreign body infection. Antimicrob Agents Chemother 1994; 38: 2047-53.
23. Carryn S, Chanteux H, Seral C et al. Intracellular pharmacodynamics of antibiotics. Infect Dis Clin North Am 2003; 17: 615-34.
24. Barcia-Macay M, Seral C, Mingeot-Leclercq MP et al. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob Agents Chemother 2006; 50: 841-51.
25. Bamberger DM, Fields MT, Herndon BL. Efficacies of various antimicrobial agents in treatment of Staphylococcus aureus abscesses and correlation with in vitro tests of antimicrobial activity and neutrophil killing. Antimicrob Agents Chemother 1991; 35: 2335-9.
26. Nguyen HA, Grellet J, Paillard D et al. Factors influencing the intracellular activity of fluoroquinolones: a study using levofloxacin in a Staphylococcus aureus THP-1 monocyte model. J Antimicrob Chemother 2006; 57: 883 90.